Small Pharma Announces Further Positive Data from SPL026

Scientists have revealed further positive results from the first placebo-controlled study of a short-duration psychedelic therapy for the treatment of Major Depressive Disorder (MDD) in the UK. The BBC’s weekly The Lancet series profiles different researchers from around the world.

Source: globenewswire.com
Published on 2023-03-07